LivaNova PLC Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by LivaNova PLC on January 16, 2018. The report addresses the closing of a previously announced acquisition transaction.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than periodic financial performance data.
Material Changes
On January 16, 2018, LivaNova PLC completed the acquisition of the remaining outstanding interests of ImThera Medical, Inc. This transaction was originally announced on December 5, 2017.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors related to the transaction. It references a press release (Exhibit 99.1) for further details on the acquisition agreement.
Investor Verification Checklist
- Verify the total consideration paid for the remaining interests of ImThera Medical, Inc. by reviewing the referenced press release (Exhibit 99.1).
- Confirm the impact of this acquisition on LivaNova's consolidated financial statements in the next quarterly or annual report.
- Review the terms of the original acquisition agreement announced on December 5, 2017, to understand any contingent liabilities or earn-out provisions.